Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

751
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
751
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

67.1K
Overview
67.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

907
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
907
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

1.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailoring Zeolite Nanosheets via Protozeolite-Directed Growth for Enhanced Methanol-to-Propylene Conversion.

Journal of the American Chemical Society·2026
Same author

Protein Corona-Tailored Nanoplatform Boosts Tumor Accumulation and Reprograms Macrophages for Osteosarcoma Therapy.

Nano letters·2026
Same author

Stabilizing sub-2 nm δ-Bi<sub>2</sub>O<sub>3</sub> via strong lanthanide-oxide-support interaction for durable CO<sub>2</sub> electroreduction to formate.

Nature communications·2026
Same author

A Hydrogen-Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self-Sustaining Catalytic Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Clarifying the origin of pseudocapacitance from a perspective of RuO<sub>2</sub>.

Communications chemistry·2026
Same author

Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression.

Molecular cancer·2026

Related Experiment Video

Updated: Jun 6, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K

Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia

Yuanyuan Li1, Wen Wu1, Qihui Liu1

  • 1Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University, Changchun, China.

Nature Communications
|November 29, 2024
PubMed
Summary

Iron oxide nanoparticles (IONPs) with specific surface coatings can modulate immune responses for treating acute myeloid leukemia (AML). Carboxymethyl dextran-coated IONPs activate immune cells, reducing leukemia burden, while other coatings may cause immune exhaustion.

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

20.9K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Related Experiment Videos

Last Updated: Jun 6, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

20.9K
Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Area of Science:

  • Nanomedicine
  • Immunology
  • Biochemistry

Background:

  • Protein corona formation on nanomaterials influences their biological interactions.
  • Understanding nanoparticle-protein corona interactions is crucial for developing effective nanotherapies.
  • The immune effects of protein corona in acute myeloid leukemia (AML) immunotherapy remain unclear.

Purpose of the Study:

  • To investigate the protein corona formation mechanism and immune regulatory effects of iron oxide nanoparticles (IONPs) in AML mouse models.
  • To explore how different surface modifications on IONPs impact immune responses.
  • To identify potential therapeutic strategies for AML using surface-engineered IONPs.

Main Methods:

  • Utilized commercialized iron oxide nanoparticles (IONPs) with varying surface modifications, including carboxymethyl dextran (IONP-COOH) and aminated dextran coatings.
  • Employed mouse models with depleted macrophages or knockout of Complement Component 3 (C3).
  • Analyzed immune responses, phagocytosis by macrophages, and complement pathway activation (alternative and lectin pathways).

Main Results:

  • IONP-COOH demonstrated a reduction in leukemia burden in AML mouse models.
  • IONP-COOH activated the complement alternative pathway, leading to C3b binding and enhanced macrophage phagocytosis.
  • Aminated dextran-coated IONPs directly absorbed C3b, activated the lectin pathway, and resulted in immune cell exhaustion.

Conclusions:

  • Surface chemistry of IONPs critically dictates their immune effects and therapeutic potential in AML.
  • IONP-COOH shows promise as an immune activator for AML treatment by leveraging complement-mediated phagocytosis.
  • Tailoring nanoparticle surface modifications offers a viable strategy for developing advanced immunotherapies.